0001415889-21-001176.txt : 20210302
0001415889-21-001176.hdr.sgml : 20210302
20210302182834
ACCESSION NUMBER: 0001415889-21-001176
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210226
FILED AS OF DATE: 20210302
DATE AS OF CHANGE: 20210302
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lampropoulos Justin J.
CENTRAL INDEX KEY: 0001643609
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-18592
FILM NUMBER: 21705875
MAIL ADDRESS:
STREET 1: 1600 WEST MERIT PARKWAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIT MEDICAL SYSTEMS INC
CENTRAL INDEX KEY: 0000856982
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 870447695
STATE OF INCORPORATION: UT
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1600 WEST MERIT PARK WAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
BUSINESS PHONE: 8012531600
MAIL ADDRESS:
STREET 1: 1600 WEST MERIT PARKWAY
CITY: SOUTH JORDAN
STATE: UT
ZIP: 84095
4
1
form4-03022021_030315.xml
X0306
4
2021-02-26
0000856982
MERIT MEDICAL SYSTEMS INC
MMSI
0001643609
Lampropoulos Justin J.
1600 WEST MERIT PARKWAY
SOUTH JORDAN
UT
84095
false
true
false
false
PRESIDENT, EMEA
Common Stock, No Par Value
2021-02-26
4
A
0
3315
0
A
3315
D
Common Stock, No Par Value
2021-02-26
4
F
0
972
55.72
D
2343
D
Non-qualified stock options (right to buy)
12.06
2015-10-04
2021-10-04
Common Stock
5000
5000
D
Non-qualified stock options (right to buy)
17.27
2016-02-13
2022-02-13
Common Stock
20000
20000
D
Non-qualified stock options (right to buy)
16.05
2017-01-28
2023-01-28
Common Stock
20000
20000
D
Non-qualified stock options (right to buy)
28.20
2018-04-14
2024-04-14
Common Stock
25000
25000
D
Non-qualified stock options (right to buy)
44.80
2019-03-02
2025-03-02
Common Stock
20000
20000
D
Non-qualified stock options (right to buy)
55.73
2020-03-01
2026-03-01
Common Stock
30000
30000
D
Non-qualified stock options (right to buy)
37.71
2021-02-26
2027-02-26
Common Stock
16722
16722
D
These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on February 26, 2020.
Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
The number of securities underlying these stock options was incorrectly reported in the Form 4 filed on 02/28/2020. All previously reported transactions involving these stock options are correct.
The number of securities beneficially owned was incorrectly reported in the Form 4 filed on 02/28/2020. All previously reported transactions involving these stock options are correct.
Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018
Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
/s/ Brian G. Lloyd, Attorney-in-Fact
2021-03-02